SCNLF
Price:
$0.27618
Market Cap:
$212.75M
Scancell Holdings plc is a biopharmaceutical company in the clinical development stage, focused on creating novel vaccines and antibody-based treatments. Its mission is to tackle significant unmet medical needs in both cancer and infectious diseases. The firm's developing therapies include SCIB1, an ImmunoBody cancer vaccine specifically for metastatic melanoma; the SCIB2/iSCIB2 vaccine, currently being evaluated for its effectiveness against various solid tumors, such as non-small cell lung cancer; and Modi-1, which is progressing through Phase I/II clinical trials for head and neck, triple-negative breast, ovarian, and renal cancers. Additionally, Scancell is working on Modi-2, designed to...[Read more]
Industry
Biotechnology
IPO Date
2013-08-02
Stock Exchange
OTC
Ticker
SCNLF
According to Scancell Holdings plc’s latest financial reports and current stock price. The company's current PE Ratio is -27.62. This represents a change of -210.59% compared to the average of 24.97 of the last 4 quarters.
The mean historical PE Ratio of Scancell Holdings plc over the last ten years is -14.09. The current -27.62 PE Ratio has changed 19.50% with respect to the historical average. Over the past ten years (40 quarters), SCNLF's PE Ratio was at its highest in in the April 2025 quarter at 112.89. The PE Ratio was at its lowest in in the September 2013 quarter at -22.23.
Average
-14.09
Median
-9.37
Minimum
-56.24
Maximum
-3.61
Discovering the peaks and valleys of Scancell Holdings plc PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 483.03%
Maximum Annual PE Ratio = -3.61
Minimum Annual Increase = -81.00%
Minimum Annual PE Ratio = -56.24
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -8.50 | -35.27% |
| 2024 | -13.13 | 22.91% |
| 2023 | -10.68 | -81.00% |
| 2022 | -56.24 | 483.03% |
| 2021 | -9.65 | 42.76% |
| 2020 | -6.76 | 87.06% |
| 2019 | -3.61 | -60.27% |
| 2018 | -9.09 | 0.66% |
| 2017 | -9.03 | -36.38% |
| 2016 | -14.20 | -43.01% |
The current PE Ratio of Scancell Holdings plc (SCNLF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-10.77
5-year avg
-19.64
10-year avg
-14.09
Scancell Holdings plc’s PE Ratio is less than Botanix Pharmaceuticals Limited (-0.51), less than Innate Pharma S.A. (-2.89), greater than NDT Pharmaceuticals Inc. (-3395.40), less than Molecular Partners AG (-2.02), less than Brii Biosciences Limited (-2.80), less than Hofseth BioCare ASA (-3.84), less than Kintor Pharmaceutical Limited (-4.64), less than Poolbeg Pharma PLC (-9.47), less than NervGen Pharma Corp. (-8.54), less than Orexo AB (publ) (-3.01),
| Company | PE Ratio | Market cap |
|---|---|---|
| -0.51 | $48.06M | |
| -2.89 | $154.94M | |
| -3395.40 | $84.22M | |
| -2.02 | $181.93M | |
| -2.80 | $107.82M | |
| -3.84 | $65.82M | |
| -4.64 | $160.37M | |
| -9.47 | $64.80M | |
| -8.54 | $312.89M | |
| -3.01 | $63.23M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Scancell Holdings plc using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Scancell Holdings plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Scancell Holdings plc's PE Ratio?
How is the PE Ratio calculated for Scancell Holdings plc (SCNLF)?
What is the highest PE Ratio for Scancell Holdings plc (SCNLF)?
What is the 3-year average PE Ratio for Scancell Holdings plc (SCNLF)?
What is the 5-year average PE Ratio for Scancell Holdings plc (SCNLF)?
How does the current PE Ratio for Scancell Holdings plc (SCNLF) compare to its historical average?